ARTBIO
Sanjay Sharma is a highly experienced professional in the field of radiopharmaceuticals and drug development, currently serving as Vice President of CMC and MSAT at ARTBIO since July 2024. Sharma has held various significant roles, including Director of CMC Operations at Alpha-9 Oncology and Director of Radiopharmaceutical Manufacturing at AtomVie Global Radiopharma. Previous positions encompass Chief Scientific Officer at NUCM Associates, Vice President of Product Development at Aurora Cannabis, and Director at Alberta Health Services. Sharma's extensive educational background includes a PhD in Chemistry and multiple postdoctoral fellowships in Medicinal Chemistry from the University of Alberta, along with further specialization in Radiopharmaceutical Chemistry from ETH Zürich.
This person is not in the org chart
This person is not in any teams
ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.